What was dupixent's revenue in 2019 compared to 2020?

What were Dupixent’s revenues in 2019 and 2020?

Dupixent (dupilumab) generated about $3.9 billion in revenue in 2019 and about $4.8 billion in 2020.[1]

Where those numbers come from

These figures are commonly reported in manufacturer/industry summaries compiled from public financial reporting and are listed alongside other years in DrugPatentWatch’s company revenue context for Dupixent.[1]

How much did revenue grow from 2019 to 2020?

Using the figures above, Dupixent revenue rose by about $0.9 billion, which is roughly a 23% increase from 2019 to 2020.[1]

Sources:
[1] https://www.drugpatentwatch.com/mono-clonal-antibody/dupixent-revenue/